Published in Nat Rev Cardiol on August 14, 2012
Lifestyle-based prediction model for the prevention of CVD: the Healthy Heart Score. J Am Heart Assoc (2014) 0.91
The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial. Trials (2015) 0.78
Identifying Coronary Artery Disease in Asymptomatic Middle-Aged Sportsmen: The Additional Value of Pulse Wave Velocity. PLoS One (2015) 0.75
Coronary Artery Calcium and Carotid Artery Intima Media Thickness and Plaque: Clinical Use in Need of Clarification. J Atheroscler Thromb (2016) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
A strategy to reduce cardiovascular disease by more than 80%. BMJ (2003) 19.05
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet (2010) 18.09
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet (2012) 17.29
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
C-reactive protein levels and outcomes after statin therapy. N Engl J Med (2005) 9.47
Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA (2010) 8.90
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med (2001) 7.51
C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation (2008) 7.33
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet (2009) 6.83
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet (2010) 6.07
Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med (2011) 5.94
Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol (2010) 5.79
Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51
Association between a literature-based genetic risk score and cardiovascular events in women. JAMA (2010) 4.46
Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol (2010) 3.93
National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation (2005) 3.77
Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med (2012) 3.05
Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol (2009) 2.80
Potential clinical and economic consequences of noncardiac incidental findings on cardiac computed tomography. J Am Coll Cardiol (2009) 2.76
Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol (2010) 2.50
C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes (2008) 2.50
Optimizing statin treatment for primary prevention of coronary artery disease. Ann Intern Med (2010) 2.41
Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol (2011) 2.17
Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006. JAMA (2009) 2.10
A multimethod quality improvement intervention to improve preventive cardiovascular care: a cluster randomized trial. Ann Intern Med (2004) 1.61
Assessing risk factors as potential screening tests: a simple assessment tool. Arch Intern Med (2010) 1.55
Three reasons to abandon low-density lipoprotein targets: an open letter to the Adult Treatment Panel IV of the National Institutes of Health. Circ Cardiovasc Qual Outcomes (2012) 1.36
Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. Eur J Cardiovasc Prev Rehabil (2009) 1.28
Guideline for minimizing radiation exposure during acquisition of coronary artery calcium scans with the use of multidetector computed tomography: a report by the Society for Atherosclerosis Imaging and Prevention Tomographic Imaging and Prevention Councils in collaboration with the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr (2011) 1.15
Serum cholesterol distribution and coronary heart disease risk: observations and predictions among middle-aged population in eastern Finland. Circulation (1998) 1.13
The performance of blood pressure and other cardiovascular risk factors as screening tests for ischaemic heart disease and stroke. J Med Screen (2004) 1.13
Design of the value of imaging in enhancing the wellness of your heart (VIEW) trial and the impact of uncertainty on power. Clin Trials (2012) 0.90
Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol (2002) 35.63
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA (2010) 8.90
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med (2002) 7.77
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA (2012) 6.29
Lifetime risks of cardiovascular disease. N Engl J Med (2012) 5.95
The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med (2004) 5.77
Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA (2004) 4.27
Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med (2005) 4.24
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94
Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med (2004) 3.59
Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation (2004) 3.44
Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA (2011) 3.44
The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med (2002) 3.32
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med (2012) 3.29
Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol (2012) 3.24
High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol (2012) 3.11
Time to end the mixed--and often incorrect--messages about prevention and treatment of atherosclerotic cardiovascular disease. J Am Coll Cardiol (2007) 3.11
LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2007) 3.08
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Association between cardiovascular outcomes and antihypertensive drug treatment in older women. JAMA (2004) 2.90
Physical performance in peripheral arterial disease: a slower rate of decline in patients who walk more. Ann Intern Med (2006) 2.73
Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med (2007) 2.62
Prevalence and cardiovascular disease correlates of low cardiorespiratory fitness in adolescents and adults. JAMA (2005) 2.47
Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA (2004) 2.45
Midlife body mass index and hospitalization and mortality in older age. JAMA (2006) 2.36
Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. J Am Coll Cardiol (2010) 2.34
Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med (2006) 2.32
Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol (2011) 2.16
Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med (2008) 2.01
Association of small artery elasticity with incident cardiovascular disease in older adults: the multi-ethnic study of atherosclerosis. Am J Epidemiol (2011) 2.01
Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry). Am J Cardiol (2006) 2.01
Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke (2004) 1.99
Predictive utility of pulse pressure and other blood pressure measures for cardiovascular outcomes. Hypertension (2007) 1.93
Favorable cardiovascular risk profile in middle age and health-related quality of life in older age. Arch Intern Med (2003) 1.84
Association of nonmelanoma skin cancer with second malignancy. Cancer (2004) 1.82
When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk. Arch Intern Med (2005) 1.78
Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci (2012) 1.76
Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J (2009) 1.71
Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age. JAMA (2004) 1.70
Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2014) 1.65
Time for the medical profession to act: new policies needed now on interactions between pharmaceutical companies and physicians. Arch Intern Med (2009) 1.61
The relation between body size perception and change in body mass index over 13 years: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Epidemiol (2009) 1.57
Can attention control conditions have detrimental effects on behavioral medicine randomized trials? Psychosom Med (2012) 1.57
Evaluation of measures of urinary albumin excretion in epidemiologic studies. Am J Epidemiol (2004) 1.54
34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol (2003) 1.52
What if the patient were your mother? Arch Intern Med (2005) 1.52
Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study. JACC Cardiovasc Imaging (2012) 1.52
Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation (2003) 1.51
Activating peripheral arterial disease patients to reduce cholesterol: a randomized trial. Am J Med (2011) 1.50
Diet quality and the risk of cardiovascular disease: the Women's Health Initiative (WHI). Am J Clin Nutr (2011) 1.48
Invited commentary: Height-cardiovascular disease relation: where to go from here? Am J Epidemiol (2002) 1.47
Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality. JAMA (2007) 1.47
Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Soc Echocardiogr (2009) 1.45
Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2007) 1.44
BMI and health-related quality of life in adults 65 years and older. Obes Res (2004) 1.43
Cardiovascular risk profile earlier in life and Medicare costs in the last year of life. Arch Intern Med (2005) 1.42
Framingham risk score and prediction of coronary heart disease death in young men. Am Heart J (2007) 1.42
Relation of vegetable, fruit, and meat intake to 7-year blood pressure change in middle-aged men: the Chicago Western Electric Study. Am J Epidemiol (2004) 1.40
Association of ethnicity and socioeconomic status with judgments of body size: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol (2007) 1.39
Effect of estrogen therapy on gallbladder disease. JAMA (2005) 1.36
Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy. Arch Intern Med (2008) 1.34
Racial/Ethnic differences in subclinical atherosclerosis among adults with diabetes: the multiethnic study of atherosclerosis. Diabetes Care (2005) 1.32
N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail (2012) 1.31
Comparison of risk factors for cardiovascular mortality in black and white adults. Arch Intern Med (2006) 1.30
Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. JACC Cardiovasc Imaging (2009) 1.30
Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care (2002) 1.30
Leg strength in peripheral arterial disease: associations with disease severity and lower-extremity performance. J Vasc Surg (2004) 1.29
Eight-year blood pressure change in middle-aged men: relationship to multiple nutrients. Hypertension (2002) 1.29
Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational Study. J Gerontol A Biol Sci Med Sci (2008) 1.29
Middle age cardiovascular risk factors and abdominal aortic aneurysm in older age. Hypertension (2003) 1.28
Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: The Multi-Ethnic Study of Atherosclerosis (MESA). Circ Cardiovasc Qual Outcomes (2010) 1.27
Estrogen and progestin use and the QT interval in postmenopausal women. Ann Noninvasive Electrocardiol (2004) 1.27
Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol (2003) 1.25
Sex differences in peripheral arterial disease: leg symptoms and physical functioning. J Am Geriatr Soc (2003) 1.24
D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation (2003) 1.22
Statin use and functional decline in patients with and without peripheral arterial disease. J Am Coll Cardiol (2006) 1.20
Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med (2002) 1.19
Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2013) 1.19
Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med (2003) 1.16
D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc (2005) 1.16
Body mass index in middle age and health-related quality of life in older age: the Chicago heart association detection project in industry study. Arch Intern Med (2003) 1.15
Distribution of coronary artery calcium scores by Framingham 10-year risk strata in the MESA (Multi-Ethnic Study of Atherosclerosis) potential implications for coronary risk assessment. J Am Coll Cardiol (2011) 1.15
Lower extremity performance is associated with daily life physical activity in individuals with and without peripheral arterial disease. J Am Geriatr Soc (2002) 1.14
Association of traditional risk factors with cardiovascular death across 0 to 10, 10 to 20, and >20 years follow-up in men and women. Am J Cardiol (2008) 1.13
Strategic transformation of population studies: recommendations of the working group on epidemiology and population sciences from the National Heart, Lung, and Blood Advisory Council and Board of External Experts. Am J Epidemiol (2015) 1.13